PINK
CHEOY

CochLear Ltd ADR

Medical Devices
Healthcare

Prices are adjusted according to historical splits.

CochLear Ltd ADR Stock Price

Vitals

Today's Low:
$76.31
Today's High:
$77.1
Open Price:
$76.31
52W Low:
$57.481
52W High:
$86.1158
Prev. Close:
$76.97
Volume:
8433

Company Statistics

Market Cap.:
$10.19 billion
Book Value:
13.0385
Revenue TTM:
$1.71 billion
Operating Margin TTM:
20.8%
Gross Profit TTM:
$1.24 billion
Profit Margin:
15.26%
Return on Assets TTM:
9.09%
Return on Equity TTM:
15.18%

Company Profile

CochLear Ltd ADR had its IPO on under the ticker symbol CHEOY.

The company operates in the Healthcare sector and Medical Devices industry. CochLear Ltd ADR has a staff strength of 4,500 employees.

Stock update

Shares of CochLear Ltd ADR opened at $76.31 at the start of the last trading session i.e. 2023-03-29.

The stocks traded within a range of $76.31 - $77.1, and closed at $77.1.

This is a +0.17% increase from the previous day's closing price.

A total volume of 8,433 shares were traded at the close of the day’s session.

In the last one week, shares of CochLear Ltd ADR have increased by +1.21%.

CochLear Ltd ADR's Key Ratios

CochLear Ltd ADR has a market cap of $10.19 billion, indicating a price to book ratio of 8.1488 and a price to sales ratio of 5.5522.

In the last 12-months CochLear Ltd ADR’s revenue was $1.71 billion with a gross profit of $1.24 billion and an EBITDA of $394.30 million. The EBITDA ratio measures CochLear Ltd ADR's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, CochLear Ltd ADR’s operating margin was 20.8% while its return on assets stood at 9.09% with a return of equity of 15.18%.

In Q2, CochLear Ltd ADR’s quarterly earnings growth was a negative -16.4% while revenue growth was a positive 7.9%.

CochLear Ltd ADR’s PE and PEG Ratio

Forward PE
46.0829
Trailing PE
57.4702
PEG
0

Its diluted EPS in the last 12-months stands at $1.34 per share while it has a forward price to earnings multiple of 46.0829 and a PEG multiple of 0. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into CochLear Ltd ADR’s profitability.

CochLear Ltd ADR stock is trading at a EV to sales ratio of 5.489 and a EV to EBITDA ratio of 19.0313. Its price to sales ratio in the trailing 12-months stood at 5.5522.

CochLear Ltd ADR stock pays annual dividends of $1.45 per share, indicating a yield of 1.32% and a payout ratio of 73.68%.

Balance sheet and cash flow metrics

Total Assets
$2.47 billion
Total Liabilities
$527.60 million
Operating Cash Flow
$-29250000.00
Capital Expenditure
$11.80 million
Dividend Payout Ratio
73.68%

CochLear Ltd ADR ended 2023 with $2.47 billion in total assets and $0 in total liabilities. Its intangible assets were valued at $2.47 billion while shareholder equity stood at $1.69 billion.

CochLear Ltd ADR ended 2023 with $33.00 million in deferred long-term liabilities, $527.60 million in other current liabilities, 1276600000.00 in common stock, $455.30 million in retained earnings and $257.10 million in goodwill. Its cash balance stood at $629.30 million and cash and short-term investments were $629.30 million. The company’s total short-term debt was $78,700,000 while long-term debt stood at $0.

CochLear Ltd ADR’s total current assets stands at $1.33 billion while long-term investments were $119.10 million and short-term investments were $0. Its net receivables were $348.50 million compared to accounts payable of $232.40 million and inventory worth $270.20 million.

In 2023, CochLear Ltd ADR's operating cash flow was $-29250000.00 while its capital expenditure stood at $11.80 million.

Comparatively, CochLear Ltd ADR paid $0.74 in dividends in 2023.

Other key metrics

Current Trading Price
$77.1
52-Week High
$86.1158
52-Week Low
$57.481
Analyst Target Price
$

CochLear Ltd ADR stock is currently trading at $77.1 per share. It touched a 52-week high of $86.1158 and a 52-week low of $86.1158. Analysts tracking the stock have a 12-month average target price of $.

Its 50-day moving average was $74.86 and 200-day moving average was $70.34 The short ratio stood at 0 indicating a short percent outstanding of 0%.

Around 0% of the company’s stock are held by insiders while 0.3% are held by institutions.

Frequently Asked Questions About CochLear Ltd ADR

The stock symbol (also called stock or share ticker) of CochLear Ltd ADR is CHEOY

The IPO of CochLear Ltd ADR took place on

Similar Industry Stocks (Medical Devices)

Last Price
Chg
Chg%
Telenor ASA (TELNF)
$11.58
0.15
+1.31%
$57.93
-0.9
-1.53%
$0.81
0.03
+4.47%
$10.45
0
0%
Savills plc (SVLPF)
$11.66
0
0%
$32.7
1.34
+4.27%
$30.07
0.92
+3.16%
$26.88
0.81
+3.12%
$13.58
0.16
+1.19%

Most Active

Last Price
Chg
Chg%
$0
0
0%
$0
0
0%
$0.1
0.01
+15.56%
Bird Global (BRDS)
$0.25
0.05
+27.78%
$0.3
0.1
+49.5%

Top Gainers

Last Price
Chg
Chg%
$0
0
+58723.53%
$0
0
+20460.42%
$0.04
0.04
+6566.67%
$0.63
0
+2548.22%
$0.02
0
+1566.67%

Top Losers

Last Price
Chg
Chg%
NGC-WT (NGC-WT)
$0
-0.04
-94.66%
$0
-0.01
-80%
Imara Inc (IMRA)
$21
0
-78.71%
$0.47
-0.67
-58.76%

About

Cochlear Limited provides implantable hearing solutions for children and adults worldwide. It offers cochlear implant systems, sound processor upgrades, bone conduction systems, accessories, and other products. The company was founded in 1981 and is headquartered in Sydney, Australia.

Address

1 University Avenue, Sydney, NSW, Australia, 2109